Methylene Blue
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09241 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 28 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | bronchitis | KG + DL |
| 2 | methemoglobinemia, alpha type | KG + DL |
| 3 | methemoglobinemia due to deficiency of methemoglobin reductase | KG + DL |
| 4 | methemoglobin reductase deficiency | KG + DL |
| 5 | obstructive lung disease | KG + DL |
| 6 | pyruvate dehydrogenase E3 deficiency | KG + DL |
| 7 | dysgammaglobulinemia (disease) | KG + DL |
| 8 | laryngotracheitis | KG + DL |
| 9 | bronchial neoplasm (disease) | KG + DL |
| 10 | dermatitis | KG + DL |
| 11 | acrodermatitis chronica atrophicans | KG + DL |
| 12 | neonatal dermatomyositis | KG + DL |
| 13 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 14 | hydroa vacciniforme, familial | KG + DL |
| 15 | conjunctivitis | KG + DL |
| 16 | amyopathic dermatomyositis | KG + DL |
| 17 | acne keloid | KG + DL |
| 18 | manic bipolar affective disorder | KG + DL |
| 19 | corneal neovascularization | KG + DL |
| 20 | methemoglobinemia type 4 | KG + DL |
| 21 | pneumonia | KG + DL |
| 22 | gastroduodenitis | KG + DL |
| 23 | tracheal disease | KG + DL |
| 24 | asthma-related traits, susceptibility to | KG + DL |
| 25 | allergic asthma | KG + DL |
| 26 | intrinsic asthma | KG + DL |
| 27 | migraine with brainstem aura | KG + DL |
| 28 | dry eye syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.